Children\\\'s Health Child Psychology Child Development Psychiatry
Wednesday, June 29, 2011
Medivir, Meda renegotiate agreement for cold sores medicine, Xerese
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases, today announced that it has renegotiated the terms of its commercial partnership with Meda for Xerese, its unique marketed product for cold sores (herpes labialis).
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment